BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 22249518)

  • 1. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.
    Quarles LD
    Nat Rev Endocrinol; 2012 Jan; 8(5):276-86. PubMed ID: 22249518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.
    Quarles LD
    Exp Cell Res; 2012 May; 318(9):1040-8. PubMed ID: 22421513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple faces of fibroblast growth factor-23.
    Han X; Quarles LD
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):333-42. PubMed ID: 27219044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel regulators of phosphate homeostasis and bone metabolism.
    Jüppner H
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S3-22. PubMed ID: 17976082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel bone endocrine networks integrating mineral and energy metabolism.
    Pi M; Quarles LD
    Curr Osteoporos Rep; 2013 Dec; 11(4):391-9. PubMed ID: 24193547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of bone in phosphate metabolism.
    Fukumoto S
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic kidney disease (CKD) and bone. Regulation of calcium and phosphate metabolism by FGF23/Klotho].
    Fukumoto S
    Clin Calcium; 2009 Apr; 19(4):523-8. PubMed ID: 19329831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphate-sensing and regulatory mechanism of FGF23 production.
    Takashi Y; Fukumoto S
    J Endocrinol Invest; 2020 Jul; 43(7):877-883. PubMed ID: 32140858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis.
    Martin A; Quarles LD
    Adv Exp Med Biol; 2012; 728():65-83. PubMed ID: 22396162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-kidney axis in systemic phosphate turnover.
    Razzaque MS
    Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FGF23 and skeletal metabolism].
    Michigami T
    Clin Calcium; 2014 Jun; 24(6):879-84. PubMed ID: 24870839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23 beyond Phosphotropic Hormone.
    Takashi Y; Fukumoto S
    Trends Endocrinol Metab; 2018 Nov; 29(11):755-767. PubMed ID: 30217676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
    Prié D; Friedlander G
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF23 and Bone and Mineral Metabolism.
    Fukumoto S
    Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF23 and syndromes of abnormal renal phosphate handling.
    Bergwitz C; Jüppner H
    Adv Exp Med Biol; 2012; 728():41-64. PubMed ID: 22396161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions.
    Agoro R; White KE
    Nat Rev Nephrol; 2023 Mar; 19(3):185-193. PubMed ID: 36624273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone remodeling through a phosphate metabolism.].
    Miyamoto T
    Clin Calcium; 2017; 27(12):1745-1749. PubMed ID: 29179169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets.
    Wöhrle S; Henninger C; Bonny O; Thuery A; Beluch N; Hynes NE; Guagnano V; Sellers WR; Hofmann F; Kneissel M; Graus Porta D
    J Bone Miner Res; 2013 Apr; 28(4):899-911. PubMed ID: 23129509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.